BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8819180)

  • 1. A comparison of a new mucolytic N-acetylcysteine L-lysinate with N-acetylcysteine: airway epithelial function and mucus changes in dog.
    Tomkiewicz RP; App EM; De Sanctis GT; Coffiner M; Maes P; Rubin BK; King M
    Pulm Pharmacol; 1995 Dec; 8(6):259-65. PubMed ID: 8819180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucolytic treatment with N-acetylcysteine L-lysinate metered dose inhaler in dogs: airway epithelial function changes.
    Tomkiewicz RP; App EM; Coffiner M; Fossion J; Maes P; King M
    Eur Respir J; 1994 Jan; 7(1):81-7. PubMed ID: 8143836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive effect of dornase alfa and Nacystelyn on transportability and viscoelasticity of cystic fibrosis sputum.
    Sun F; Tai S; Lim T; Baumann U; King M
    Can Respir J; 2002; 9(6):401-6. PubMed ID: 12522485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dextran sulfate on tracheal mucociliary velocity in dogs.
    Sudo E; Boyd WA; King M
    J Aerosol Med; 2000; 13(2):87-96. PubMed ID: 11010598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dextran on tracheal mucociliary velocity in dogs in vivo.
    Feng W; Nakamura S; Sudo E; Lee MM; Shao A; King M
    Pulm Pharmacol Ther; 1999; 12(1):35-41. PubMed ID: 10208834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis.
    App EM; Baran D; Dab I; Malfroot A; Coffiner M; Vanderbist F; King M
    Eur Respir J; 2002 Feb; 19(2):294-302. PubMed ID: 11866009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in viscoelasticity in cystic fibrosis sputum in vitro using combined treatment with nacystelyn and rhDNase.
    Dasgupta B; King M
    Pediatr Pulmonol; 1996 Sep; 22(3):161-6. PubMed ID: 8893254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of myrtol standardized and other substances on the respiratory tract: ciliary beat frequency and mucociliary clearance as parameters.
    Begrow F; Böckenholt C; Ehmen M; Wittig T; Verspohl EJ
    Adv Ther; 2012 Apr; 29(4):350-8. PubMed ID: 22477544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of mucolytic agents on the rheologic and transport properties of canine tracheal mucus.
    Martin R; Litt M; Marriott C
    Am Rev Respir Dis; 1980 Mar; 121(3):495-500. PubMed ID: 6968166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tracheal mucus rheology and epithelial potential difference in two day old puppies.
    App EM; King M
    Biorheology; 1990; 27(3-4):515-26. PubMed ID: 2261517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nacystelyn, a novel lysine salt of N-acetylcysteine, to augment cellular antioxidant defence in vitro.
    Gillissen A; Jaworska M; Orth M; Coffiner M; Maes P; App EM; Cantin AM; Schultze-Werninghaus G
    Respir Med; 1997 Mar; 91(3):159-68. PubMed ID: 9135855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of expectorants on the canine tracheal ciliated cells.
    Yanaura S; Imamura N; Misawa M
    Jpn J Pharmacol; 1981 Dec; 31(6):957-65. PubMed ID: 7334738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rheology of bronchial secretions and mucociliary transport (author's transl)].
    Puchelle E; Girard F; Zahm JM
    Bull Eur Physiopathol Respir; 1976; 12(6):771-9. PubMed ID: 1016804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Improved Inhaled Mucolytic to Treat Airway Muco-obstructive Diseases.
    Ehre C; Rushton ZL; Wang B; Hothem LN; Morrison CB; Fontana NC; Markovetz MR; Delion MF; Kato T; Villalon D; Thelin WR; Esther CR; Hill DB; Grubb BR; Livraghi-Butrico A; Donaldson SH; Boucher RC
    Am J Respir Crit Care Med; 2019 Jan; 199(2):171-180. PubMed ID: 30212240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous surfactant enhances mucociliary clearance in the anaesthetized dog.
    De Sanctis GT; Tomkiewicz RP; Rubin BK; Schürch S; King M
    Eur Respir J; 1994 Sep; 7(9):1616-21. PubMed ID: 7995390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucus altering agents as adjuncts for nonviral gene transfer to airway epithelium.
    Ferrari S; Kitson C; Farley R; Steel R; Marriott C; Parkins DA; Scarpa M; Wainwright B; Evans MJ; Colledge WH; Geddes DM; Alton EW
    Gene Ther; 2001 Sep; 8(18):1380-6. PubMed ID: 11571577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of guaifenesin, N-acetylcysteine, and ambroxol on MUC5AC and mucociliary transport in primary differentiated human tracheal-bronchial cells.
    Seagrave J; Albrecht HH; Hill DB; Rogers DF; Solomon G
    Respir Res; 2012 Oct; 13(1):98. PubMed ID: 23113953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new paradigm in respiratory hygiene: modulating respiratory secretions to contain cough bioaerosol without affecting mucus clearance.
    Zayas G; Valle JC; Alonso M; Alfaro H; Vega D; Bonilla G; Reyes M; King M
    BMC Pulm Med; 2007 Aug; 7():11. PubMed ID: 17697323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetylcysteine inhibits Na+ absorption across human nasal epithelial cells.
    Rochat T; Lacroix JS; Jornot L
    J Cell Physiol; 2004 Oct; 201(1):106-16. PubMed ID: 15281093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheology of mucus and transepithelial potential difference: small airways versus trachea.
    App EM; Zayas JG; King M
    Eur Respir J; 1993 Jan; 6(1):67-75. PubMed ID: 8425597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.